Recent Patterns across Therapy Lines and Real-World Survival Post First Line PD-L1 Treatment for Small Cell Lung Cancer

被引：0
|
作者：
Borghaei, H. [1 ]
Shaw, J. [2 ]
Pundole, X. [2 ]
Balasubramanian, A. [2 ]
Anderson, E. [2 ]
Bebb, G. [2 ]
Jiang, T. [2 ]
Pastel, M. [2 ]
Martinez, P. [2 ]
Ramalingam, S. [3 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
small cell lung cancer; recent treatment patterns; impact of PD-L1 inhibitors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.17-01
引用
收藏
页码：S377 / S378
页数：2
相关论文
共 50 条
  • [1] Recent treatment patterns and real-world survival following first-line anti-PD-L1 treatment for extensive-stage small cell lung cancer
    Shaw, Jaime
    Pundole, Xerxes
    Balasubramanian, Akhila
    Anderson, Erik S.
    Pastel, Malaika
    Bebb, D. Gwyn
    Jiang, Tony
    Martinez, Pablo
    Ramalingam, Suresh S.
    Borghaei, Hossein
    ONCOLOGIST, 2024, 29 (12): : 1079 - 1089
  • [2] Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer
    Peng, Jianfeng
    Zhang, Lemeng
    Wang, Liping
    Feng, Hui
    Yao, Dongmei
    Meng, Rui
    Liu, Xiaomei
    Li, Xiaohua
    Liu, Ningbo
    Tan, Bingxu
    Huang, Zhaoqin
    Li, Shanshan
    Meng, Xiangjiao
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [3] Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer
    Jianfeng Peng
    Lemeng Zhang
    Liping Wang
    Hui Feng
    Dongmei Yao
    Rui Meng
    Xiaomei Liu
    Xiaohua Li
    Ningbo Liu
    Bingxu Tan
    Zhaoqin Huang
    Shanshan Li
    Xiangjiao Meng
    Radiation Oncology, 18
  • [4] Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the United States
    Veluswamy, Rajwanth
    Hirsch, Fred R.
    Taioli, Emanuela
    Wisnivesky, Juan
    Strauss, Ross
    Harrough, Douglas
    Tang, Boxiong
    Barnes, Gisoo
    CANCER MEDICINE, 2022, 11 (22): : 4265 - 4272
  • [5] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [6] A REAL-WORLD ANALYSIS OF TREATMENT PATTERNS FOR FIRST-LINE IMMUNOTHERAPIES AMONG DANISH PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND PD-L1 EXPRESSION $50%
    Clugston, D. M.
    Beck, C.
    Bjerregaard, B. K.
    Kristensen, E. S.
    VALUE IN HEALTH, 2023, 26 (12) : S514 - S514
  • [7] A real-world study of PD-L1 testing patterns and PD-1/PD-L1 inhibitor therapy in patients with metastatic non-small cell lung cancer: An analysis of the Sotiria Hospital lung cancer registry
    Charpidou, Andriani
    Syrigos, Nikolaos K.
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Tsagouli, Sofia
    Burke, Thomas
    Spanoudi, Filio
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Gkiozos, Ioannis
    PNEUMON, 2024,
  • [8] The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level
    Ondrusova, Martina
    Suchansky, Martin
    Svidova, Sona VaNDOR
    Chowaniecova, Gabriela
    Mrinakova, Bela
    Sekeresova, Monika
    Juskanic, Dominik
    Ondrus, Dalibor
    Senitko, Michal
    NEOPLASMA, 2024, 71 (05)
  • [9] PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data
    Apter, L.
    Moser, S. Sharman
    Arunachalam, A.
    Burke, T.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S307 - S308
  • [10] Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel
    Moser, Sarah Sharman
    Apter, Lior
    Arunachalam, Ashwini
    Burke, Thomas
    Shalev, Varda
    Chodick, Gabriel
    Siegelmann-Danieli, Nava
    IMMUNOTHERAPY, 2021, 13 (10) : 851 - 861
12345